EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Cronos Group's Enterprise Value is $83.40 Mil.
Cronos Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-46.26 Mil. Therefore, Cronos Group's EV-to-FCF for today is -1.80.
The historical rank and industry rank for Cronos Group's EV-to-FCF or its related term are showing as below:
CRON'
s EV-to-FCF Range Over the Past 10 Years
Min: -59.96 Med: -7.72 Max: 2.26
Current: -0.75
During the past 10 years, the highest EV-to-FCF of Cronos Group was 2.26. The lowest was -59.96. And the median was -7.72.
CRON's EV-to-FCF is ranked worse than 100% of 508
companies
in the Drug Manufacturers industry
Industry Median: 21.86
vs CRON: -0.75
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-24), Cronos Group's stock price is $2.46.
Cronos Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.184. Therefore, Cronos Group's PE Ratio for today is At Loss.
Cronos Group EV-to-FCF Historical Data
The historical data trend for Cronos Group's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cronos Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cronos Group EV-to-FCF Distribution
For the Drug Manufacturers industry and Healthcare sector, Cronos Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Cronos Group's EV-to-FCF falls into.
Cronos Group EV-to-FCF Calculation
Cronos Group's EV-to-FCF for today is calculated as:
Cronos Group's current Enterprise Value is $83.40 Mil.
Cronos Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-46.26 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cronos Group (NAS:CRON) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Cronos Group's PE Ratio for today is calculated as:
Cronos Group's share price for today is $2.46.
Cronos Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.184.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Cronos Group EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Cronos Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CRON has been successfully added to your 